Want to see AU:AHC full AI Analyst Report?
AHC Stock Chart & Stats
AU$0.22
>-AU$0.01(-2.22%)
At close: 4:00 PM EDT
AU$0.22
>-AU$0.01(-2.22%)
Day’s Range― - ―
52-Week RangeAU$0.19 - AU$0.45
Previous CloseN/A
Volume362.21K
Average Volume (3M)242.22K
Market Cap
AU$84.32M
Enterprise ValueAU$73.02M
Total Cash (Recent Filing)AU$15.23M
Total Debt (Recent Filing)AU$7.68M
Price to Earnings (P/E)10.7
Beta0.73
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding374,751,280
10 Day Avg. Volume336,746
30 Day Avg. Volume242,221
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)2.08
Price to Sales (P/S)1.32
P/FCF Ratio10.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.45Price Target Upside104.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.03
Revenue Forecast (FY)AU$115.65M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Healthy Gross MarginSustained revenue expansion combined with a 52% gross margin indicates durable demand and effective product pricing. This level of gross margin supports reinvestment in R&D, product integration and services, underpinning long-term competitive positioning and margin resilience.
Low Financial Leverage And Strong Capital StructureVery low leverage and a majority equity-funded asset base reduce bankruptcy and refinancing risk, providing strategic flexibility. This capital strength enables funding of growth initiatives or M&A and helps the company withstand healthcare sector cyclicality over time.
Solid Cash Conversion Of EarningsHigh conversion of accounting earnings into cash indicates genuine cash generation capacity. Reliable operating cash flow supports sustainable investment in product development, recurring service contracts and working capital needs without dependence on external financing.
Bears Say
Declining Net Profit MarginA material fall in net margin suggests rising operating costs or one-off pressures that erode bottom-line profitability. If persistent, margin compression reduces free cash available for reinvestment, weakens returns to shareholders and narrows buffers against downturns.
Slowing Free Cash Flow GrowthSlower FCF growth limits the company’s ability to accelerate product investment, expand service capacity or pursue acquisitions. Over time, constrained cash growth may force trade-offs among capex, R&D and shareholder returns, reducing strategic optionality.
Negative EPS GrowthA substantial decline in EPS indicates earnings per share weakness that may reflect dwindling profitability or share dilution. Prolonged EPS contraction undermines shareholder returns and can constrain management’s ability to fund long-term initiatives without altering capital structure.
AHC FAQ
What was Austco Healthcare Limited’s price range in the past 12 months?
Austco Healthcare Limited lowest share price was AU$0.19 and its highest was AU$0.45 in the past 12 months.
What is Austco Healthcare Limited’s market cap?
Austco Healthcare Limited’s market cap is AU$84.32M.
When is Austco Healthcare Limited’s upcoming earnings report date?
Austco Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 15 days.
How were Austco Healthcare Limited’s earnings last quarter?
Austco Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.013 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.013.
Is Austco Healthcare Limited overvalued?
According to Wall Street analysts Austco Healthcare Limited’s price is currently Undervalued.
Does Austco Healthcare Limited pay dividends?
Austco Healthcare Limited pays a Semiannually dividend of AU$0.002 which represents an annual dividend yield of N/A. See more information on Austco Healthcare Limited dividends here
What is Austco Healthcare Limited’s EPS estimate?
Austco Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Austco Healthcare Limited have?
Austco Healthcare Limited has 374,751,280 shares outstanding.
What happened to Austco Healthcare Limited’s price movement after its last earnings report?
Austco Healthcare Limited reported an EPS of AU$0.013 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.515%.
Which hedge fund is a major shareholder of Austco Healthcare Limited?
Currently, no hedge funds are holding shares in AU:AHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Austco Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.45 (104.55% Upside)
AU$0.45 (104.55% Upside)
Blogger Sentiment
Bullish
AU:AHC Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
68.75%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.80%
Trailing 12-Months
Company Description
Austco Healthcare Limited
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends across Australia, New Zealand, Asia, Europe, and North America. A significant product in its portfolio is Tacera, an internet protocol (IP) based nurse call solution specifically engineered for both hospitals and aged care facilities. Originally founded in 1986, the company adopted its current name, Austco Healthcare Limited, in November 2020, having previously been known as Azure Healthcare Limited. Its corporate headquarters are located in Port Melbourne, Australia.
AHC Stock 12 Month Forecast
Average Price Target
AU$0.45
▲(104.55% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Paragon Care Limited
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―







